Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1996 Jun;73(12):1538–1544. doi: 10.1038/bjc.1996.290

Analysis of cAMP RI alpha mRNA expression in breast cancer: evaluation of quantitative polymerase chain reaction for routine use.

J M Bartlett 1, M J Hulme 1, W R Miller 1
PMCID: PMC2074559  PMID: 8664126

Abstract

A quantitative polymerase chain reaction (PCR) method for determining concentrations of mRNA for the cyclic AMP (cAMP)-binding protein RI alpha, a regulatory subunit of cAMP-dependent protein kinase, was developed using site-directed mutagenic primers and mix-melt PCR. The PCR product for RI alpha mRNA was modified to include an EcoRV restriction site for use as an internal standard. This mutant utilised the same primers as the target mRNA and differed in sequence by only four bases. As only one of these base changes results in a purine/pyrimidine switch the effective change in labelling with [32P]dCTP was less than 0.5%. Reverse transcription of mRNA was performed and quantitative PCR was carried out using fixed levels of mutant RI alpha vs varying amounts of both normal RI alpha sequence of known concentration and unknown samples. Validation of the technique using rigourous quality control established that reverse transcription, determined by incorporation of labelled nucleotides, gave intra- and interassay variations of 16.2 and 9.3% respectively. Using crossover evaluation of cDNA concentrations with cloned RI alpha sequences as controls intra- and interassay variations of 14.3% and 4-8% respectively were obtained. Using compounded errors, the limits of precision for this technique demonstrate that values that are altered by 50% or more represent a true alteration in mRNA levels between samples tested. This value compares favourably to similar values for radioimmunoassays of between 10% and 30% precision. Analysis of a series of patient samples during routine follow-up of treatment demonstrated clear changes in mRNA levels. Using site-directed mutagenesis to establish a quantitative PCR-based assay for expression of mRNA this study demonstrates the potential usefulness and some limitations of quantitative PCR for applications within a clinical biochemistry laboratory. However, based on compounded error, values that vary by less than 50% within assays, and by less than 70% in separate assays could not be clearly separated. Assessment of paired patient samples has demonstrated clear changes in mRNA for the target protein RI alpha. With the use of normal quality control procedures this study has established that the degree of reproducibility of this quantitative PCR technique would allow assessment of mRNA levels for markers of interest in clinical samples in a routine laboratory context.

Full text

PDF
1538

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bartlett J. M., Weinbauer G. F., Nieschlag E. Quantitative analysis of germ cell numbers and relation to intratesticular testosterone following vitamin A-induced synchronization of spermatogenesis in the rat. J Endocrinol. 1989 Dec;123(3):403–412. doi: 10.1677/joe.0.1230403. [DOI] [PubMed] [Google Scholar]
  2. Bartlett J. M., Wu F. C., Sharpe R. M. Enhancement of Leydig cell testosterone secretion by isolated seminiferous tubules during co-perifusion in vitro: comparison with static co-culture systems. Int J Androl. 1987 Aug;10(4):603–617. doi: 10.1111/j.1365-2605.1987.tb00360.x. [DOI] [PubMed] [Google Scholar]
  3. Battersby S., Anderson T. J., Miller W. R. Patterns of cyclic AMP binding in normal human breast. Breast Cancer Res Treat. 1994;30(2):153–158. doi: 10.1007/BF00666059. [DOI] [PubMed] [Google Scholar]
  4. Bianchi D. W., Shuber A. P., DeMaria M. A., Fougner A. C., Klinger K. W. Fetal cells in maternal blood: determination of purity and yield by quantitative polymerase chain reaction. Am J Obstet Gynecol. 1994 Oct;171(4):922–926. doi: 10.1016/s0002-9378(94)70059-1. [DOI] [PubMed] [Google Scholar]
  5. Brodeur G. M., Seeger R. C., Schwab M., Varmus H. E., Bishop J. M. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science. 1984 Jun 8;224(4653):1121–1124. doi: 10.1126/science.6719137. [DOI] [PubMed] [Google Scholar]
  6. Chan A., Zhao J., Krajden M. Polymerase chain reaction kinetics when using a positive internal control target to quantitatively detect cytomegalovirus target sequences. J Virol Methods. 1994 Jul;48(2-3):223–236. doi: 10.1016/0166-0934(94)90121-x. [DOI] [PubMed] [Google Scholar]
  7. Cho-Chung Y. S. Suppression of malignancy targeting cyclic AMP signal transducing proteins. Biochem Soc Trans. 1992 May;20(2):425–430. doi: 10.1042/bst0200425. [DOI] [PubMed] [Google Scholar]
  8. Frye R. A., Benz C. C., Liu E. Detection of amplified oncogenes by differential polymerase chain reaction. Oncogene. 1989 Sep;4(9):1153–1157. [PubMed] [Google Scholar]
  9. Izutani R., Ohyanagi H., MacDermott R. P. Quantitative PCR for detection of femtogram quantities of interleukin-8 mRNA expression. Microbiol Immunol. 1994;38(3):233–237. doi: 10.1111/j.1348-0421.1994.tb01770.x. [DOI] [PubMed] [Google Scholar]
  10. Jessen-Eller K., Picozza E., Crivello J. F. Quantitation of metallothionein mRNA by RT-PCR and chemiluminescence. Biotechniques. 1994 Nov;17(5):962–973. [PubMed] [Google Scholar]
  11. Lubin M. B., Elashoff J. D., Wang S. J., Rotter J. I., Toyoda H. Precise gene dosage determination by polymerase chain reaction: theory, methodology, and statistical approach. Mol Cell Probes. 1991 Aug;5(4):307–317. doi: 10.1016/0890-8508(91)90054-n. [DOI] [PubMed] [Google Scholar]
  12. Lyttelton M. P., Hart S., Ganeshaguru K., Hoffbrand A. V., Mehta A. B. Quantitation of multidrug resistant MDR1 transcript in acute myeloid leukaemia by non-isotopic quantitative cDNA-polymerase chain reaction. Br J Haematol. 1994 Mar;86(3):540–546. doi: 10.1111/j.1365-2141.1994.tb04784.x. [DOI] [PubMed] [Google Scholar]
  13. Miller W. R., Watson D. M., Jack W., Chetty U., Elton R. A. Tumour cyclic AMP binding proteins: an independent prognostic factor for disease recurrence and survival in breast cancer. Breast Cancer Res Treat. 1993;26(1):89–94. doi: 10.1007/BF00682703. [DOI] [PubMed] [Google Scholar]
  14. Raval P. Qualitative and quantitative determination of mRNA. J Pharmacol Toxicol Methods. 1994 Nov;32(3):125–127. doi: 10.1016/1056-8719(94)90065-5. [DOI] [PubMed] [Google Scholar]
  15. Sandberg M., Skålhegg B., Jahnsen T. The two mRNA forms for the type I alpha regulatory subunit of cAMP-dependent protein kinase from human testis are due to the use of different polyadenylation site signals. Biochem Biophys Res Commun. 1990 Feb 28;167(1):323–330. doi: 10.1016/0006-291x(90)91768-n. [DOI] [PubMed] [Google Scholar]
  16. Seeger R. C., Brodeur G. M., Sather H., Dalton A., Siegel S. E., Wong K. Y., Hammond D. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med. 1985 Oct 31;313(18):1111–1116. doi: 10.1056/NEJM198510313131802. [DOI] [PubMed] [Google Scholar]
  17. Sheffield L. G. Oligonucleotides antisense to catalytic subunit of cyclic AMP-dependent protein kinase inhibit mouse mammary epithelial cell DNA synthesis. Exp Cell Res. 1991 Jan;192(1):307–310. doi: 10.1016/0014-4827(91)90191-v. [DOI] [PubMed] [Google Scholar]
  18. Siebert P. D., Larrick J. W. Competitive PCR. Nature. 1992 Oct 8;359(6395):557–558. doi: 10.1038/359557a0. [DOI] [PubMed] [Google Scholar]
  19. Underwood M. A., Bartlett J. M., Cooke T. G. An improved method for semiquantification of gene amplification from archival material. PCR Methods Appl. 1994 Dec;4(3):178–184. doi: 10.1101/gr.4.3.178. [DOI] [PubMed] [Google Scholar]
  20. Withoff S., Smit E. F., Meersma G. J., van den Berg A., Timmer-Bosscha H., Kok K., Postmus P. E., Mulder N. H., de Vries E. G., Buys C. H. Quantitation of DNA topoisomerase II alpha messenger ribonucleic acid levels in a small cell lung cancer cell line and two drug resistant sublines using a polymerase chain reaction-aided transcript titration assay. Lab Invest. 1994 Jul;71(1):61–66. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES